Cargando…
Perspectives on Using Physcomitrella Patens as an Alternative Production Platform for Thapsigargin and Other Terpenoid Drug Candidates
To overcome the potential future demand for terpenoids used as drugs, a new production platform is currently being established in our laboratory. The moss Physcomitrella has been chosen as the candidate organism for production of drug candidates based on terpenoids derived from plants, with a primar...
Autores principales: | Simonsen, Henrik Toft, Drew, Damian Paul, Lunde, Christina |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754923/ https://www.ncbi.nlm.nih.gov/pubmed/19812738 |
Ejemplares similares
-
In vivo assembly of DNA-fragments in the moss, Physcomitrella patens
por: King, Brian Christopher, et al.
Publicado: (2016) -
Insights into Heterologous Biosynthesis of Arteannuin B and Artemisinin in Physcomitrella patens
por: Ikram, Nur Kusaira Khairul, et al.
Publicado: (2019) -
Stable Production of the Antimalarial Drug Artemisinin in the Moss Physcomitrella patens
por: Khairul Ikram, Nur Kusaira Binti, et al.
Publicado: (2017) -
Metabolic engineering of the moss Physcomitrella patens to produce the sesquiterpenoids patchoulol and α/β-santalene
por: Zhan, Xin, et al.
Publicado: (2014) -
Corrigendum: In vivo assembly of DNA-fragments in the moss, Physcomitrella patens
por: King, Brian Christopher, et al.
Publicado: (2016)